Experimental Medicine is part of the Nuffield Department of Clinical Medicine, University of Oxford. Staff are based at the John Radcliffe Hospital, the Churchill Hospital, the Peter Medawar Building for Pathogen Research, the Weatherall Institute of Molecular Medicine and the Nuffield Orthopaedic Hospital.
Administration support for Experimental Medicine is based on Level 5 of the John Radcliffe Hospital in Headington with research units having their own admin support attached to where they are based.
During the developing COVID-19 pandemic, NDM Experimental Medicine is taking measures to prevent the spread of the disease.
Departments are instructed by the University's Registrar to continue to work from home where possible, and manage the return to on site working, based on the University guidelines for risk assessments and work prioritisation.
This is to restrict contact between individuals as far as possible. The University remains open and operating as far as possible with the following restrictions:
- No public access to the University
- On-site activity permitted where it cannot be undertaken remotely, driven by safety, capacity and other factors such as schools reopening/other changes in government guidelines
- Teaching and assessment are undertaken remotely where possible and, depending on government guidelines, gatherings of staff and students only permitted where essential for teaching and assessment to take place
21 September 2021
The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.
20 September 2021
‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. Designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.
Oxford IBD MasterClass 2022
Immunology and Immuno-Modulatory Therapy in Inflammatory Bowel Disease: Bench to Bedside
Unfortunately, due to the Coronavirus Pandemic we have decided to postpone the Oxford IBD MasterClass 2021 and reschedule for September 2022.
Our intention is to keep the agenda in line with the programme we designed this year, but we will be re-assessing to ensure the latest cutting-edge developments are shared with you.
Full details for 2022 will be shared in due course and registration will open later in the year. If you like us to notify you when registration is open please send an email to OMC2021@ndm.ox.ac.uk
Podcast: Meet our Researchers
Before translating basic research into the clinic it is important first to undergo clinical trials in order to identify safe treatments and therapies for disease. Led by Prof Simon Travis, the Gastroenterology Clinical Trials Facility at Oxford University works to translate basic research into clinical trials of novel therapies for gastrointestinal and liver diseases.
The Nuffield Department of Medicine operates unit-based formal mentoring schemes for all externally funded research fellows.
We currently have a large number of postgraduate students studying within Experimental Medicine.
Jobs and Vacancies
There is a wide range of opportunities in the Experimental Medicine Division.